A role of melatonin in the treatment of low back pain | All the latest summaries on the portal Medznat.ru. :- Medznat
EN | RU
EN | RU

Help Support

By clicking the "Submit" button, you accept the terms of the User Agreement, including those related to the processing of your personal data. More about data processing in the Policy.
Back

A role of melatonin in the treatment of low back pain

A role of melatonin in the treatment of low back pain A role of melatonin in the treatment of low back pain
A role of melatonin in the treatment of low back pain A role of melatonin in the treatment of low back pain

To study an analgesic role of melatonin in the treatment of low back pain.

See All

Key take away

Melatonin is a manmade form of a hormone produced in the brain that helps regulate your sleep and wake cycle. In this original research, melatonin is regarded as a drug of choice in the treatment of low back pain due to its therapeutic efficacy and good tolerability. 

Background

To study an analgesic role of melatonin in the treatment of low back pain.

Method

A study included 178 patients, aged from 40 to 65 years, with low back pain during at least 12 weeks and the VAS score > 3. Patients were stratified into 6 groups (3 pairs of comparison). In the first pair, patients of the main group (n = 31) received APTPA (a combination of 500 mg of glucosamine hydrochloride and 500 mg of chondroitin sulfate) in dosage 1 tablet twice a day during 1 month and then 1 tablet during 2 months plus melaxen (3 mg of melatonin 30-40 min before sleep), patients of the control group (n = 29) received only APTPA. In the second pair, patients of the comparison group (n = 30) received APTPA in dosage 1 tablet twice a day and diclofenac in dosage 25 mg 2-3 times a day, patients of the main group (n = 30) received additionally melaxen (3 mg of melatonin 30-40 min before sleep). In the third pair, patients of the main group (n = 29) received APTPA in dosage 1 tablet twice a day, diclofenac in dosage 25 mg 2-3 times a day and melaxen (3 mg of melatonin 30-40 min before sleep), patients of the comparison group (n = 29) did not receive melaxen. Treatment results were assessed after 3 months for the first pair and after 1 month for the second and third pairs.

Result

A significant reduction in pain intensity at movement and resting state was noted in the main groups compared to controls.

Conclusion

Possible mechanisms of analgesic properties of melatonin and world experience in chronic low back pain treatment are discussed.

Source:

Zh Nevrol Psikhiatr Im S S Korsakova. 2015

Article:

A role of melatonin in the treatment of low back pain

Authors:

Kurganova YM, Danilov AB

Comments (0)

You want to delete this comment? Please mention comment Invalid Text Content Text Content cannot me more than 1000 Something Went Wrong Cancel Confirm Confirm Delete Hide Replies View Replies View Replies en
Try: